Insilico

"The mini-labs provide a flexible test environment that delivers real measurement data," Gamella said in a statement. "They're a bit like a playground for algorithms, where researchers can test their AI beyond simulated data in a controlled and safe environment."

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

Data from AbbVie and Johnson & Johnson will fine-tune OpenFold3 in a confidentiality-preserving environment, powered by Apheris.

Over two million have been found in America; they are not from this world. Google DeepMind's materials AI has already discovered new crystals

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO says can "understand the concept of time and how you change, from cradle to grave.

The company is building AI models to help find new materials that can help combat climate change.

The National Synchrotron Light Source II (NSLS-II)—a U.S. Department of Energy (DOE) Office of Science user facility at DOE's Brookhaven National Laboratory—is among the world's most advanced synchrotron light sources,

Iktos, a global leader in AI-driven drug discovery, has secured a prestigious €2.5 million grant from the European Innovation Council (EIC) Accelerator to advance its AI and robotics synthesis automation technology.